CD163 and neoplasm: In our application, we stitch cross-platform slices from Xenium and Visium, enabling rich and precise characterizations of tumor ecosystems, which help us identify the immune cells undetected before (CD4 T cells, CD8 T cells and CD163 macrophages) for Visium data and enlarge the limited gene coverage of Xenium data.